PF-06804103 Dose Escalation in HER2 Positive and Negative (Negative Only in Part 2) Solid Tumors

Clinical trial NCT03284723 · TERMINATED

Trial details

NCT number: NCT03284723
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2017-11-01
Primary completion: 2021-08-31
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.